Form 483

Bio Protech, Inc. Form 483, 2026-04-09

FDA issued a Form 483 to Bio Protech, Inc. on 2026-04-09 with 3 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health3 observations

Bio Protech, Inc. · Wonju-Si, Korea (the Republic of) · Issued April 9, 2026

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Apr 2026
ISO 13485:2016 Clause 6.4.1(a)

Requirements for personnel health, cleanliness, and clothing not documented

Cited by Naakesh N Gomanie

9 Apr 2026
ISO 13485:2016 Clause 7.5.7

Processes for sterilization and sterile barrier systems not validated

Cited by Naakesh N Gomanie

9 Apr 2026
ISO 13485:2016 Clause 8.2.5

Monitoring/measurement methods do not show QMS processes meet planned results

Cited by Naakesh N Gomanie

Inspected site

BPBio Protech, Inc.Wonju-Si, Korea (the Republic of)

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
ISO 13485:2016 Clause 6.4.1(a)Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.5.7Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.2.5Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere